tiprankstipranks
Armata Pharmaceuticals Inc (ARMP)
NYSE MKT:ARMP

Armata Pharmaceuticals (ARMP) Financial Statements

247 Followers

Armata Pharmaceuticals Financial Overview

Armata Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.204; its P/E ratio is -1.15; Armata Pharmaceuticals is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 3.73M$ 1.23M--$ 1.11M
Gross Profit$ 1.53M$ 1.23M---
EBIT-$ -29.98M$ -3.55M$ -14.49M$ -10.27M
EBITDA-$ -29.76M$ -3.25M$ -14.29M$ -9.97M
Net Income Common Stockholders$ -19.85M$ -31.16M$ -3.55M$ -14.49M$ -10.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.50M$ 24.00M$ 12.50M$ 25.10M$ 14.85M
Total Assets$ 98.36M$ 112.76M$ 101.26M$ 108.78M$ 95.83M
Total Debt$ 120.37M$ 113.63M$ 68.31M$ 77.33M$ 48.81M
Net Debt$ 106.87M$ 89.63M$ 55.81M$ 52.23M$ 33.96M
Total Liabilities$ 130.43M$ 125.15M$ 82.07M$ 86.33M$ 59.75M
Stockholders Equity$ -32.06M$ -12.39M$ 19.14M$ 22.45M$ 36.08M
Cash Flow-
Free Cash Flow$ -10.50M$ -13.24M$ -12.21M$ -19.61M$ -10.03M
Operating Cash Flow$ -8.11M$ -9.73M$ -11.99M$ -17.60M$ -10.48M
Investing Cash Flow$ -2.39M$ -3.51M$ -222.00K$ -2.01M$ 455.00K
Financing Cash Flow$ -43.00K$ 24.80M$ -368.00K$ 29.59M$ -500.00K
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

Armata Pharmaceuticals Debt to Assets

Armata Pharmaceuticals Cash Flow

Armata Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis